Search Results
Resources : dbGaP
Resources
All of Us
BPC
BTB
CancerModels.Org
cBioPortal
CBTRUS
CCDI
CCSS
CEDCD
CGC
CGCI
Childhood Cancer Repository
CIViC
COG
CRI iAtlas
dbGaP
DCEG
DepMap
Fibroregistry
GDC
GENIE
GEO
HCMI
HitWalker2
HTAN
iCat
IDC
ITCC P4
JAX PDX
Kids First Data Resource
M3Cs
MTP
MyPART
NCCB
NCTN
NCTN Biobanks
NICD
Oncogenomics
OncoKB
OSE
PCAT
PCDC
PDX AIM
PDXNet
PEDC
PedMATCH
PPTC
PROSPR
ScPCA
SRL
St. Jude Cloud
TARGET
TCIA
TCPA
Texas KidsCanSeq
TPC-DTC_PIVOT
Treehouse
VIVO
Vizome
VPCC
WHO-IARC
Xena Browser
Card View
Table View
Alveolar Soft Part SarcomaClear Cell SarcomaDesmoplastic Small Round Cell TumorEndodermal Sinus TumorHepatoblastomaMelanomaNeuroblastomaOsteosarcomaRhabdomyosarcomaSarcoma...
267
401
Malignancy remains the leading cause of disease-related death in children. DNA sequencing studies have shown a paucity of actionable genomic alterations and a low mutation burden across pediatric cancers at diagnosis. We perform a comprehensive genomic and epigenomic analysis of pediatric tumor and normal tissues using next-generation sequencing to identify molecular fingerprints and targets for diagnosis, prognosis, and development of novel therapeutic methods. This study also represents one of ...
Osteosarcoma
5
7
Lung metastasis is responsible for nearly all deaths caused by osteosarcoma, the most common pediatric bone tumor. How malignant bone cells coerce the lung microenvironment to support metastatic growth is unclear. This study delineates how osteosarcoma cells educate the lung microenvironment during metastatic progression.
Project
Acute Megakaryoblastic Leukemia
15
RNA SequencingWhole Exome SequencingWhole Genome Sequencing
33
To define the mutation spectrum in non-Down syndrome acute megakaryoblastic leukemia (non-DS-AMKL), we performed transcriptome sequencing on diagnostic blasts from 14 pediatric patients and validated our findings in a recurrency/validation cohort consisting of 34 pediatric and 28 adult AMKL samples. Our analysis identified a cryptic chromosome 16 inversion (inv(16)(p13.3q24.3)) in 27% of pediatric cases, which encodes a CBFA2T3-GLIS2 fusion protein. Expression of CBFA2T3-GLIS2 in Drosophila and ...
Alveolar RhabdomyosarcomaEmbryonal RhabdomyosarcomaOther
920
920
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. While these malignancies display aberrant myogenic differentiation, relatively little is known about genetic susceptibility to RMS, or how genetic variants influence subsequent somatic events and may be used in risk stratification strategies. A small percentage of cases are associated with mutations in TP53 (Li-Fraumeni syndrome), HRAS (Costello syndrome), and PTCH1 (nevoid basal cell carcinoma syndrome/Gorlin syndrome), ...
Pediatric High-Grade Glioma
61
122
Pediatric high-grade gliomas (pHGGs), encompassing diffuse midline gliomas (DMGs) and hemispheric tumors, represent the most common cause of cancer-related deaths in children age 0-14 years. Over the last decade, several landmark papers have revealed recurrent single nucleotide variants (SNVs) in the core histones H3.3 and H3.1, co-occurring with alterations in the TP53 signaling pathway and receptor tyrosine kinases (RTKs). However, the contribution of structural variants (SVs) to gliomagenesis ...
Hodgkin Lymphoma
445
1,281
In this study, we show that the plasma representation of mutations exceeds the bulk tumor representation in most cases, making classic Hodgkin Lymphoma (cHL) particularly amenable to noninvasive profiling. Leveraging single-cell transcriptional profiles of cHL tumors, we demonstrate hazard ratios (HRs) circulating tumor DNA (ctDNA) shedding to be shaped by DNASE1L3, whose increased tumor microenvironment-derived expression drives high ctDNA concentrations. Using this insight, we comprehensively ...
Rhabdomyosarcoma
124
295
In this study, we evaluated circulating tumor DNA (ctDNA) as a biomarker in the serum of 124 patients with newly diagnosed intermediate risk rhabdomyosarcoma (IR RMS) from the Children's Oncology Group (COG) biorepository. In addition to pre-treatment serum, we also analyzed matched tumor tissue and germline in a subset of patients. We profiled samples using ultra-low passage whole genome sequencing (ULP-WGS) and a new custom hybrid-capture sequencing assay, Rhabdo-Seq, to detect copy number alt ...
Diffuse Intrinsic Pontine GliomaThalamic Diffuse Midline Glioma
10
29
Tumor molecular profiling is increasingly important for the diagnosis and clinical management of childhood brain tumors, including diffuse midline glioma (DMG). We established a targeted deep sequencing approach using the TruSight Oncology 500 ctDNA exome panel to detect tumor genomic mutations and copy number variations in circulating tumor DNA from children diagnosed with DMG. In this study, we present the sensitivity, specificity, and clinical implications of our liquid biopsy sequencing appr ...
Rhabdomyosarcoma
12
66
This study (10-C-0086) collected and analyzed tumor and circulating tumor omics of pediatric and young adult patients with relapsed rhabdomyosarcoma who were co-enrolled in and receiving treatment on the interventional study 17-C-0049. We sought to describe the summary genomic findings of tumors, and report on the detection of circulating tumor DNA (ctDNA) in serial samples. Tumor tissue and blood were collected and analyzed. Tumor samples were subjected to whole exome and/or whole genome sequen ...
NeuroblastomaOsteosarcoma
15
103
This study is a retrospective correlative analysis of immune cell phenotypes in samples from a Phase I clinical trial (NCT02107963) of GD2 CAR-T cells (GD2-CAR.OX40.28.z.iC9) in children and young adults with osteosarcoma and neuroblastoma.